CE Mark and ISO, SFDA certificate
Clinical sensitivity: >87%
Clinical specificity: >98.89%
Clinical report is available on request, specimen: whole blood/serum, 15 minutes to get results.
- Rapid 2019-nCoV InG/IgM Combo Test Cassette
- Sample buffer
- 2mL capillary pipet
- Instruction sheet
This kit is used for the qualitative detection of the antibody of the COVID-19 in human blood, serum or plasma. It is mainly used for clinical reference. Tests are intended to be used on patients exhibiting symptoms of COVID-19. They will be expected to show positive 7 days after infection and/or 3 days after the onset of symptoms.
CE quality marked.
According to the principle of double antibody sandwich method, the kit uses immunochromatographic technology to detect the IgG/IgM antibody of C OVID-19 in human serum/ plasma/whole blood. The C OVID-19 characteristic protein RBD protein antibody in the sample binds to the colloidal gold labeled RBD protein, and the mixture is chromatographed to the kit T1 line and T2 line combining to the mouse anti-human IgG/IgM antibody respectively to form a visible detection line.
1: These are professional test kits and should be used under medical supervision.
2: Negative results do not guarantee you are virus free or that you will or will not contract the virus.